Nanofiber implant delivers three drugs, doubles survival in glioblastoma mice
Scientists from the University of Cincinnati and Johns Hopkins Medicine created a nanofiber implant containing multiple drugs that work together to combat glioblastoma, a type of brain cancer. The implant was more effective than individual drugs and delivered sustained treatment, leading to doubled survival rates in mice with the disease. This approach shows promise for improving cancer therapy by combining targeted drug delivery with prolonged action.
Scientists created a nanofiber implant that delivers three drugs together to treat brain cancer in mice, doubling their survival rates.
This approach shows promise for more effective and sustained treatment of aggressive brain cancers like glioblastoma.
It highlights innovative medical research that could lead to better therapies and improved outcomes for patients with difficult-to-treat cancers.
upbeatBytes summarizes in its own words and links to the original publisher — it doesn't host the article.